UK 
United States
- 01/04/2026
HR Grapevine
HR, Benefits and Reward leaders are entering a tougher renewal cycle. Global medical costs are projected to rise by 10.3% in 2026, while 55% of insurers expect elevated costs to persist for more than three years. At the same time, finance teams are asking sharper questions: what is driving spend, what can be controlled, and which benefits can prove measurable return?
This guide helps HR and Benefits leaders look beyond the visible invoice. It explores where workforce health costs really build - across PMI claims, occupational health, absence, productivity loss and an ageing workforce - and why MSK is becoming one of the most addressable areas to control before costs escalate.
What you will learn in this report:
Why the double-digit medical trend is becoming the new baseline for benefits renewals, not a temporary spike.
Where hidden workforce health costs build before they appear as claims - across PMI, occupational health, absence and productivity loss.
Why MSK has moved into the top tier of global cost drivers, and why it is one of the most addressable areas for earlier intervention.
How to estimate hidden exposure, potential savings, ROI and payback before renewal
At Vitrue Health, we empower businesses to cultivate healthier, more productive workplaces by addressing musculoskeletal (MSK) health challenges before they arise. By leveraging advanced AI and elite sport science principles, we proactively predict, prevent, and reduce issues before they occur, keeping teams healthy, productive and pain-free.
Eliminate pain and elevate health with Vitrue Health, so your teams can stay focused, energised, and performing at their best.
